Aug 2 (Reuters) – Pfizer Inc reported
better-than-expected quarterly results, driven by lower taxes
and sales of generic medicines, but revenue from its branded
patent-protected medicines brought…
The post UPDATE 4-Pfizer beats estimates, but branded drugs disappoint appeared first on NASDAQ.